Skip to main content
4th of July Sale — Get 40% off Vantage subscriptions
Published loading...Updated

Oruka Stock Is Now Up Nearly 700%. Here's What a $687,000 Insider Sale Could Mean

Summary by The Motley Fool
Key PointsAn Oruka Therapeutics executive reported selling 9,854 directly held Common Stock shares for a total value of $687K based on a weighted average price of $69.72 per share as of June 15, 2026.This transaction represented 36.83% of Arjun Agarwal's direct Common Stock holdings prior to the trade, reducing his direct ownership to 16,899 shares.The disposition involved only direct holdings; no indirect entities participated, and the activity…
4th of July SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States on Saturday, June 27, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal